Rate My Professor Clement Loy

Professor Loy's academic interests lie in molecular genetics and clinical epidemiology, particularly Huntington Disease, genetic dementias, and clinical trials. He has published 119 papers and book chapters in esteemed journals including JAMA, The Lancet, New England Journal of Medicine, Cell, BMJ, Annals of Neurology, Lancet Neurology, and Brain. Key recent publications are 'What is the prevalence of sleep disturbances among people with Huntington disease and pre-manifest genetic expansion carriers? A systematic review and meta-analysis' (Sleep Medicine Reviews, 2026, with N.J. Sneddon et al.) and 'Effective housing and support models for people with Huntington's disease: a scoping review' (Journal of Huntington's Disease, 2025, with L. Cubis et al.). He has attracted more than $25 million in research funding and currently holds $6 million in grants and contracts as Chief Investigator A, along with one patent. Loy serves on the Pharmaceutical Benefits Advisory Committee, contributes to governance of the international Huntington Study Group, and is an elected councillor for the Hospitals Contribution Fund. His leadership and research significantly influence neurodegenerative disease management and advancement.